144 related articles for article (PubMed ID: 21824981)
1. Tolerability profile of aripiprazole in patients with Tourette syndrome.
Cavanna AE; Selvini C; Termine C; Luoni C; Eddy CM; Rickards H
J Psychopharmacol; 2012 Jun; 26(6):891-5. PubMed ID: 21824981
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients.
Wenzel C; Kleimann A; Bokemeyer S; Müller-Vahl KR
J Clin Psychopharmacol; 2012 Aug; 32(4):548-50. PubMed ID: 22722499
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole for the treatment of adolescent Tourette's syndrome: a case report.
Lewis K; Rappa L; Sherwood-Jachimowicz DA; Larose-Pierre M
J Pharm Pract; 2010 Jun; 23(3):239-44. PubMed ID: 21507820
[TBL] [Abstract][Full Text] [Related]
4. Treatment of tics in tourette syndrome with aripiprazole.
Kastrup A; Schlotter W; Plewnia C; Bartels M
J Clin Psychopharmacol; 2005 Feb; 25(1):94-6. PubMed ID: 15643108
[No Abstract] [Full Text] [Related]
5. [Aripiprazole for the treatment of Tourette's syndrome].
Stenstrøm AD; Sindø I
Ugeskr Laeger; 2008 Jan; 170(1):58. PubMed ID: 18208720
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months.
Neuner I; Nordt C; Schneider F; Kawohl W
Hum Psychopharmacol; 2012 Jul; 27(4):364-9. PubMed ID: 22700477
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.
Budman C; Coffey BJ; Shechter R; Schrock M; Wieland N; Spirgel A; Simon E
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):509-15. PubMed ID: 18928415
[TBL] [Abstract][Full Text] [Related]
10. [Aripiprazole - a medical treatment alternative for Tourette Syndrome in childhood and adolescence].
Frölich J; Starck M; Banaschewski T; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2010 Jul; 38(4):291-8. PubMed ID: 20617499
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole in childhood and adolescence for Tourette syndrome.
Duane DD
J Child Neurol; 2006 Apr; 21(4):358. PubMed ID: 16900939
[No Abstract] [Full Text] [Related]
12. A pilot study of aripiprazole in children and adolescents with Tourette's disorder.
Yoo HK; Kim JY; Kim CY
J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):505-6. PubMed ID: 16958578
[No Abstract] [Full Text] [Related]
13. Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation.
Gibson AP; Crismon ML; Mican LM; Fischer C
Int Clin Psychopharmacol; 2007 Mar; 22(2):101-5. PubMed ID: 17293710
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome.
Rizzo R; Eddy CM; Calí P; Gulisano M; Cavanna AE
Pediatr Neurol; 2012 Dec; 47(6):419-22. PubMed ID: 23127261
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole in patients with Tourette syndrome.
Bubl E; Perlov E; Tebartz Van Elst L
World J Biol Psychiatry; 2006; 7(2):123-5. PubMed ID: 16684686
[TBL] [Abstract][Full Text] [Related]
16. [Aripiprazole use in children and adolescent psychiatric patients].
Chevreuil C; Polard E; Lemonnier E; Guillemot P; Bentué-Ferrer D;
Therapie; 2011; 66(2):123-30. PubMed ID: 21635859
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
Lyon GJ; Samar S; Jummani R; Hirsch S; Spirgel A; Goldman R; Coffey BJ
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Findling RL
J Clin Psychiatry; 2011 Sep; 72(9):1270-6. PubMed ID: 21813076
[TBL] [Abstract][Full Text] [Related]
20. A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole.
Davies L; Stern JS; Agrawal N; Robertson MM
Hum Psychopharmacol; 2006 Oct; 21(7):447-53. PubMed ID: 17029306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
